Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of baricitinib in steroid-resistant or relapsed immune thrombocytopenia: An open-label pilot study.
Zhao P, An ZY, Fu HX, Liu HX, Feng CJ, Huang QS, Wu J, Wu YJ, Yang LP, Qu QY, Chen YX, Li ML, Wang CC, Chen Q, Zhu XL, He Y, Zhang YY, Jiang Q, Jiang H, Lu J, Chang YJ, Zhao XS, Zhao XY, Huang XJ, Zhang XH. Zhao P, et al. Am J Hematol. 2024 Oct;99(10):1951-1958. doi: 10.1002/ajh.27433. Epub 2024 Jul 9. Am J Hematol. 2024. PMID: 38980207 Clinical Trial.
Molecular measurable residual disease before transplantation independently predicts survival and relapse risk in adult lysine methyltransferase 2a-rearranged acute myeloid leukemia.
Wang L, Chen Y, Zang M, Zhou J, Xiao M, Fu H, Mo X, Wang F, Han W, Zhang Y, Yan C, Wang Z, Han T, Lv M, Chen H, Chen Y, Chen Y, Wang J, Wang Y, Xu L, Liu K, Huang X, Zhang X. Wang L, et al. Cancer. 2025 Jan 15;131(2):e35717. doi: 10.1002/cncr.35717. Cancer. 2025. PMID: 39760486